2-107988201-C-T
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The ENST00000264047.3(SLC5A7):c.46C>T(p.Leu16Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00138 in 1,614,090 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L16I) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000264047.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC5A7 | NM_021815.5 | c.46C>T | p.Leu16Phe | missense_variant | 2/9 | ENST00000264047.3 | NP_068587.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC5A7 | ENST00000264047.3 | c.46C>T | p.Leu16Phe | missense_variant | 2/9 | 1 | NM_021815.5 | ENSP00000264047 | P1 | |
SLC5A7 | ENST00000409059.5 | c.46C>T | p.Leu16Phe | missense_variant | 2/9 | 1 | ENSP00000387346 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000986 AC: 150AN: 152178Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00175 AC: 440AN: 251474Hom.: 1 AF XY: 0.00197 AC XY: 268AN XY: 135908
GnomAD4 exome AF: 0.00142 AC: 2071AN: 1461794Hom.: 5 Cov.: 30 AF XY: 0.00151 AC XY: 1099AN XY: 727210
GnomAD4 genome AF: 0.000985 AC: 150AN: 152296Hom.: 0 Cov.: 33 AF XY: 0.000994 AC XY: 74AN XY: 74458
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:2
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Mar 20, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 27, 2024 | See Variant Classification Assertion Criteria. - |
Likely benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Mar 07, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2022 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 28, 2019 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Neuronopathy, distal hereditary motor, type 7A;C4310694:Congenital myasthenic syndrome 20 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
SLC5A7-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 14, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at